The Journal of Immunology, Vol 147, Issue 7 2130-2135, Copyright © 1991 by American Association of Immunologists

ARTICLES

Humoral recall responses in HIV infection. Levels, specificity, and affinity of antigen-specific IgG

EN Janoff, WD Hardy, PD Smith and SM Wahl
Department of Medicine, Veterans Affairs Medical Center, University of Minnesota School of Medicine, Minneapolis 55417.

To evaluate the integrity of humoral immunologic memory among persons with HIV infection, we measured the levels, specificity, and functional affinity of circulating antibodies to vaccine-related recall Ag, tetanus (TT) and diphtheria toxoids (DT), and to naturally acquired measles virus, in sera from 17 HIV-seronegative control subjects, 17 asymptomatic HIV-seropositive patients, and 10 patients with AIDS. Preimmunization levels of TT- and measles-specific IgG were similar in all groups, although DT-specific IgG was lower in AIDS patients. Four wk after immunization with TT3 and DT, all groups showed significantly increased specific antibody levels (p less than 0.02). The asymptomatic HIV+ patients and control subjects achieved similar peak serum levels of TT-specific IgG (102 +/- 32 and 169 +/- 36 micrograms/ml, respectively). In contrast, the AIDS patients had lower peak values of both TT- and DT- specific IgG (p less than 0.05). Peak levels correlated directly with the number of CD4+ T cells (p less than 0.05). However, 80 to 100% of all participants tested, independent of HIV status, showed higher levels of TT- and DT-specific IgG 6 mo after immunization compared with preimmunization levels. The antitoxoid antibodies were specific as they did not cross-react with other Ag in competitive inhibition experiments. In addition, all groups exhibited antibodies to TT and DT both pre- and postimmunization of equivalent functional affinity (avidity) (Kd = 10(-10)-10(-11) mol/liter). We conclude that, in contrast to the profoundly depressed humoral responses to new Ag, persons with asymptomatic HIV infection retain humoral immunity to certain recall Ag. These levels of specific IgG to three recall Ag are not proportional to elevated levels of total serum IgG in HIV-infected patients. In addition, many patients with HIV respond to challenge with recall Ag by producing significant amounts of high affinity IgG that may persist over time.

This article has been cited by other articles:

				N. J. Mantis, J. Palaia, A. J. Hessell, S. Mehta, Z. Zhu, B. Corthesy, M. R. Neutra, D. R. Burton, and E. N. Janoff Inhibition of HIV-1 Infectivity and Epithelial Cell Transfer by Human Monoclonal IgG and IgA Antibodies Carrying the b12 V Region J. Immunol., September 1, 2007; 179(5): 3144 - 3152. [Abstract] [Full Text] [PDF]

				C. E. Fasching, T. Grossman, B. Corthesy, A. G. Plaut, J. N. Weiser, and E. N. Janoff Impact of the Molecular Form of Immunoglobulin A on Functional Activity in Defense against Streptococcus pneumoniae Infect. Immun., April 1, 2007; 75(4): 1801 - 1810. [Abstract] [Full Text] [PDF]

				K. Titanji, A. De Milito, A. Cagigi, R. Thorstensson, S. Grutzmeier, A. Atlas, B. Hejdeman, F. P. Kroon, L. Lopalco, A. Nilsson, et al. Loss of memory B cells impairs maintenance of long-term serologic memory during HIV-1 infection Blood, September 1, 2006; 108(5): 1580 - 1587. [Abstract] [Full Text] [PDF]

				G. Badr, G. Borhis, D. Treton, C. Moog, O. Garraud, and Y. Richard HIV Type 1 Glycoprotein 120 Inhibits Human B Cell Chemotaxis to CXC Chemokine Ligand (CXCL) 12, CC Chemokine Ligand (CCL)20, and CCL21 J. Immunol., July 1, 2005; 175(1): 302 - 310. [Abstract] [Full Text] [PDF]

				J. N. Weiser, D. Bae, C. Fasching, R. W. Scamurra, A. J. Ratner, and E. N. Janoff Antibody-enhanced pneumococcal adherence requires IgA1 protease PNAS, April 1, 2003; 100(7): 4215 - 4220. [Abstract] [Full Text] [PDF]

				P. J. Carson, K. L. Nichol, J. O'Brien, P. Hilo, and E. N. Janoff Immune Function and Vaccine Responses in Healthy Advanced Elderly Patients Arch Intern Med, July 10, 2000; 160(13): 2017 - 2024. [Abstract] [Full Text] [PDF]

				R. W. Scamurra, D. J. Miller, L. Dahl, M. Abrahamsen, V. Kapur, S. M. Wahl, E. C. B. Milner, and E. N. Janoff Impact of HIV-1 Infection on VH3 Gene Repertoire of Naive Human B Cells J. Immunol., May 15, 2000; 164(10): 5482 - 5491. [Abstract] [Full Text] [PDF]

				F. P. Kroon, M. J. D. van Tol, C. M. Jol-van der Zijde, R. van Furth, and J. T. van Dissel Immunoglobulin G (IgG) Subclass Distribution and IgG1 Avidity of Antibodies in Human Immunodeficiency Virus-Infected Individuals after Revaccination with Tetanus Toxoid Clin. Vaccine Immunol., May 1, 1999; 6(3): 352 - 355. [Abstract] [Full Text] [PDF]

				L. Hougs, L. Juul, H. J. Ditzel, C. Heilmann, A. Svejgaard, and T. Barington The First Dose of a Haemophilus influenzae Type b Conjugate Vaccine Reactivates Memory B Cells: Evidence for Extensive Clonal Selection, Intraclonal Affinity Maturation, and Multiple Isotype Switches to IgA2 J. Immunol., January 1, 1999; 162(1): 224 - 237. [Abstract] [Full Text] [PDF]

				L. Juompan, P. Lambin, and M. Zouali Selective deficit in antibodies specific for the superantigen binding site of gp120 in HIV infection FASEB J, November 1, 1998; 12(14): 1473 - 1480. [Abstract] [Full Text]

				Y. Hieda, D. E. Keyler, J. T. Vandevoort, J. K. Kane, C. A. Ross, D. E. Raphael, R. S. Niedbalas, and P. R. Pentel Active Immunization Alters the Plasma Nicotine Concentration in Rats J. Pharmacol. Exp. Ther., December 1, 1997; 283(3): 1076 - 1081. [Abstract] [Full Text]

				S. K. Stanley, M. A. Ostrowski, J. S. Justement, K. Gantt, S. Hedayati, M. Mannix, K. Roche, D. J. Schwartzentruber, C. H. Fox, and A. S. Fauci Effect of Immunization with a Common Recall Antigen on Viral Expression in Patients Infected with Human Immunodeficiency Virus Type 1 N. Engl. J. Med., May 9, 1996; 334(19): 1222 - 1229. [Abstract] [Full Text] [PDF]